ATG Awarded $3.5 Million Department of Energy Contract For Waste Removal and Processing.Business Editors FREMONT, Calif.--(BUSINESS WIRE)--April 11, 2000 ATG ATG antithymocyte globulin. lymphocyte immune globulin (antithymocyte globulin equine, ATG, ATG equine, LIG) Atgam Pharmacologic class: Immunoglobulin Therapeutic class: Immunosuppressant Inc. (Nasdaq:ATGC ATGC Adenine,Thymine, Guanine, & Cytosine ATGC Asiantaeth Trwyddedu Hywyr A Cherbydau (Welsh: Driver and Vehicle Licensing Agency, UK) ), a leading provider of low-level radioactive and mixed waste treatment services, today announced that it has been awarded a $3.5 million contract by Brookhaven National Laboratory Brookhaven National Laboratory, scientific research center, at Upton (town of Brookhaven), Long Island, N.Y. It was founded in 1947 by Associated Universities, a management corporation sponsored by nine eastern U.S. universities. , a United States Department of Energy The United States Department of Energy (DOE) is a Cabinet-level department of the United States government responsible for energy policy and nuclear safety. Its purview includes the nation's nuclear weapons program, nuclear reactor production for the United States Navy, facility on Long Island in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . The two-year contract calls for the removal, packaging and processing of the designated wastes located in Brookhaven's Hazardous Waste Hazardous waste Any solid, liquid, or gaseous waste materials that, if improperly managed or disposed of, may pose substantial hazards to human health and the environment. Every industrial country in the world has had problems with managing hazardous wastes. Management Facility. The contract includes the on-site characterization, sampling, engineering, licenses regulating permits, approved waste profile, and transportation documentation and packaging of the low-level radioactive waste Noun 1. low-level radioactive waste - (medicine) radioactive waste consisting of objects that have been briefly exposed to radioactivity (as in certain medical tests) that has been stockpiled at the Brookhaven facility. The waste will then be transported to ATG's Richland, Wash. facility for treatment, and final disposition of the waste will occur at approved disposal facilities. Under the contract, ATG will provide a variety of services, including thermal and non-thermal processing capabilities, brokerage services, and general waste management services. "Our wide array of value-added service solutions, coupled with our strong relationship with the DOE, helped in this contract win," said Doreen Chiu, president and chief executive officer of ATG. "Going forward we expect to continue our relationship with the DOE as we work to win additional business from the commercial and other government sectors, both here and overseas." ATG is a radioactive and hazardous waste management company that offers comprehensive thermal and non-thermal treatment solutions for low-level radioactive and low-level mixed waste generated by commercial entities such as nuclear power plants, medical facilities and research institutions, both in the United States and overseas, and by the U.S. Departments of Defense and Energy. This news release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially from those projected in the forward-looking statements as a result of various factors set forth under "Factors Affecting Future Operating Results" in the Company's annual report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and such other risks detailed from time to time in the Company's other reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion